DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Amifampridine phosphateis the generic ingredient in one branded drug marketed by Catalyst Pharms and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Amifampridine phosphate has two patent family members in two countries.
One supplier is listed for this compound.
Summary for amifampridine phosphate
Recent Clinical Trials for amifampridine phosphate
Identify potential brand extensions & 505(b)(2) entrants
|Catalyst Pharmaceuticals, Inc.||Phase 2|
|Catalyst Pharmaceuticals, Inc.||Phase 3|
|Catalyst Pharmaceuticals, Inc.||N/A|
Pharmacology for amifampridine phosphate
|Drug Class||Potassium Channel Blocker |
|Mechanism of Action||Potassium Channel Antagonists |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.